Resmed Inc Stock Ownership - Who owns Resmed?

Insider buying vs selling

Have Resmed Inc insiders been buying or selling?
Brett SandercockChief Financial Officer2024-06-101,000$209.81
Michael J. FarrellChief Executive Officer2024-06-0714,683$84.98
Michael J. FarrellChief Executive Officer2024-06-0714,683$211.66
Michael J. RiderGlobal General Counsel2024-06-04267$206.33
Witte Jan DeDirector2024-05-15360$218.29
Witte Jan DeDirector2024-05-15360$218.29
Witte Jan DeDirector2024-05-15360$218.29
Brett SandercockChief Financial Officer2024-05-0812,000$101.64
Brett SandercockChief Financial Officer2024-05-0813,000$211.37
Michael J. FarrellChief Executive Officer2024-05-0713,507$84.98

1 of 6

RMD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RMD insiders and whales buy or sell their stock.

RMD Shareholders

What type of owners hold Resmed Inc stock?
Vanguard Group Inc12.10%17,769,766$3.66BInstitution
Blackrock Inc8.30%12,194,535$2.51BInstitution
State Street Corp4.29%6,299,015$1.30BInstitution
Bank Of New York Mellon Corp2.60%3,813,119$784.85MInstitution
Geode Capital Management LLC2.33%3,423,177$704.59MInstitution
Morgan Stanley1.32%1,938,132$398.93MInstitution
Invesco Ltd1.27%1,870,615$385.03MInstitution
Christopher G. Roberts1.16%1,700,337$349.98MInsider
Fmr LLC1.10%1,614,997$332.41MInstitution
Northern Trust Corp0.97%1,422,126$292.72MInstitution

1 of 3

RMD vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RMD55.32%4.26%Net SellingNet Selling
WST92.82%3.68%Net BuyingNet Buying
COO93.32%0.86%Net Selling
BAX84.53%15.47%Net SellingNet Selling
HOLX86.52%13.48%Net SellingNet Selling

Resmed Stock Ownership FAQ

Who owns Resmed?

Resmed (NYSE: RMD) is owned by 55.32% institutional shareholders, 4.26% Resmed insiders, and 40.42% retail investors. Christopher G. Roberts is the largest individual Resmed shareholder, owning 1.70M shares representing 1.16% of the company. Christopher G. Roberts's Resmed shares are currently valued at $309.80M.

If you're new to stock investing, here's how to buy Resmed stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.